Kyverna Therapeutics Stock Quote KYTX - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

4.19

Bid

4.06

Ask

4.50

Volume

294,480

4.03 Day's Range 4.28

3.92 52 Week Range 35.01

Market Cap

180.889M

Previous Close

4.24

Open

4.21

Last Trade

4.27

Last Trade Time

Financial Volume

$ 1,221,914

VWAP

4.1494

Average Volume (3m)

350,522

Shares Outstanding

43,171,612

Dividend Yield

PE Ratio

-2.99

Earnings Per Share (EPS)

-1.4

Revenue

Net Profit

-60.37M

Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin... Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases. Kyverna's pipeline includes next-generation chimeric antigen receptor T-cell (CAR T) therapies in both autologous and allogeneic formats with properties well suited for use in B cell-driven autoimmune diseases. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

kyvernatx.com

Headquarters

Dover, Delaware, USA

Founded

Kyverna Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker KYTX. The last closing price for Kyverna Therapeutics was $4.24. Over the last year, Kyverna Therapeutics shares have traded in a share price range of $ 3.92 to $ 35.01.

Kyverna Therapeutics currently has 43,171,612 shares outstanding. The market capitalization of Kyverna Therapeutics is $183.05 million. Kyverna Therapeutics has a price to earnings ratio (PE ratio) of -2.99.

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 7, 2025 in Kyverna Therapeutics, Inc. Lawsuit - KYTX

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 7, 2025 in Kyverna Therapeutics, Inc. Lawsuit - KYTX PR Newswire NEW YORK, Dec. 16, 2024 NEW YORK, Dec. 16, 2024...

Kyverna Therapeutics Strengthens Leadership Team to Accelerate Next Phase of Growth

Kyverna Therapeutics Strengthens Leadership Team to Accelerate Next Phase of Growth PR Newswire EMERYVILLE, Calif., Dec. 13, 2024 Key Leadership Appointments Bring New Skills and Capabilities to...

Form 8-K - Current report

Kyverna Therapeutics Announces New Patient Data Highlighting Potential of KYV-101 for Treatment of Lupus Nephritis in Symposium at ACR Convergence 2024

Kyverna Therapeutics Announces New Patient Data Highlighting Potential of KYV-101 for Treatment of Lupus Nephritis in Symposium at ACR Convergence 2024 PR Newswire EMERYVILLE, Calif., Nov. 14...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.67	-13.7860082305	4.86	4.96	4.18	280889	4.48005818	CS
4	-0.1	-2.331002331	4.29	7.2	3.92	399518	4.97150172	CS
12	-1.72	-29.10321489	5.91	7.2	3.92	350522	5.03310577	CS
26	-5.43	-56.4449064449	9.62	11.4	3.92	428369	6.75589629	CS
52	-30.06	-87.7664233577	34.25	35.01	3.92	451507	12.5526187	CS
156	-30.06	-87.7664233577	34.25	35.01	3.92	451507	12.5526187	CS
260	-30.06	-87.7664233577	34.25	35.01	3.92	451507	12.5526187	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUKKNukkleus Inc	$ 11.655 (738.49%)	174.4M
PRTGPortage Biotech Inc	$ 8.8678 (172.86%)	36.61M
OPTXSyntec Optics Holdings Inc	$ 3.55 (99.44%)	93.16M
PTPIPetros Pharmaceuticals Inc	$ 0.4976 (86.37%)	63.49M
LUXHLuxUrban Hotels Inc	$ 0.849899 (59.67%)	29.52M
VCNXVaccinex Inc	$ 1.41 (-61.37%)	758.95k
TNYATenaya Therapeutics Inc	$ 1.395 (-51.56%)	42.45M
ORKTOrangeKloud Technology Inc	$ 2.14 (-41.85%)	2.29M
RVPHReviva Pharmaceuticals Holdings Inc	$ 1.395 (-39.35%)	18.16M
DBGIDigital Brands Group Inc	$ 2.46 (-37.88%)	805.23k
RIMEAlgorhythm Holdings Inc	$ 0.0877 (8.27%)	1.13B
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.335 (-36.79%)	1.02B
GOEVCanoo Inc	$ 0.118 (7.08%)	388.43M
NVDANVIDIA Corporation	$ 130.39 (-1.22%)	259.4M
XTIAXTI Aerospace Inc	$ 0.0442 (8.33%)	222.55M